Demant A/S - Asset Resilience Ratio
Demant A/S (DEMANT) has an Asset Resilience Ratio of -2.59% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read DEMANT total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2022)
This chart shows how Demant A/S's Asset Resilience Ratio has changed over time. See what is Demant A/S's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Demant A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Demant A/S worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr-838.00 Million | -2.59% |
| Total Liquid Assets | Dkr-838.00 Million | -2.59% |
Asset Resilience Insights
- Limited Liquidity: Demant A/S maintains only -2.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Demant A/S Industry Peers by Asset Resilience Ratio
Compare Demant A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 5.46% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.66% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Demant A/S (2008–2022)
The table below shows the annual Asset Resilience Ratio data for Demant A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -3.42% | Dkr-1.02 Billion ≈ $-159.74 Million |
Dkr29.86 Billion ≈ $4.67 Billion |
-0.06pp |
| 2021-12-31 | -3.36% | Dkr-836.00 Million ≈ $-130.80 Million |
Dkr24.86 Billion ≈ $3.89 Billion |
+0.06pp |
| 2020-12-31 | -3.42% | Dkr-750.00 Million ≈ $-117.34 Million |
Dkr21.93 Billion ≈ $3.43 Billion |
+0.16pp |
| 2019-12-31 | -3.58% | Dkr-780.00 Million ≈ $-122.04 Million |
Dkr21.80 Billion ≈ $3.41 Billion |
+0.50pp |
| 2018-12-31 | -4.08% | Dkr-731.00 Million ≈ $-114.37 Million |
Dkr17.93 Billion ≈ $2.81 Billion |
-4.48pp |
| 2017-12-31 | 0.41% | Dkr66.00 Million ≈ $10.33 Million |
Dkr16.22 Billion ≈ $2.54 Billion |
+0.34pp |
| 2016-12-31 | 0.07% | Dkr11.00 Million ≈ $1.72 Million |
Dkr15.55 Billion ≈ $2.43 Billion |
-0.01pp |
| 2015-12-31 | 0.08% | Dkr12.00 Million ≈ $1.88 Million |
Dkr14.39 Billion ≈ $2.25 Billion |
+0.42pp |
| 2013-12-31 | -0.34% | Dkr-35.00 Million ≈ $-5.48 Million |
Dkr10.36 Billion ≈ $1.62 Billion |
+6.05pp |
| 2008-12-31 | -6.39% | Dkr-251.00 Million ≈ $-39.27 Million |
Dkr3.93 Billion ≈ $614.30 Million |
-- |
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more